Intellijoint Surgical looking to expand their OEM business with new robotic partners

Following Success of Accelus as They Are Named Orthopedic Company to Watch in 2023

KITCHENER — Intellijoint Surgical congratulates Accelus for being listed in Bonezone’s 5 Orthopedic Companies to Watch in 2023 “because of consistent growth through development deals, the gathering of clinical evidence to back novel treatment solutions and active portfolios supported by numerous product launches.” Accelus experienced growth in 2022 through the Remi Robotic Navigation System and their FlareHawk portfolio of multidirectional expandable implants.

Intellijoint’s relationship with Accelus and their Remi Robotic Navigation System, a navigated robotic targeting system for spine surgery, began in 2020. Remi utilizes Intellijoint’s camera as a component of the system to provide enhanced line of sight and enable close positioning while tracking instruments with a broader range than other conventional systems. Remi’s workflow and small footprint make this system appealing to surgeons, reportedly saving them OR setup and planning time.

Intellijoint’s camera fills a void in the market offering reduced setup time, miniaturized OR footprint, full control from within the sterile field and no line-of-sight issues.

“Intellijoint Surgical had the camera solution we needed to bring our innovative spine robotic navigation platform to market,” said, Brad Clayton, Accelus Chief Technology Officer. “Remi is the perfect complement to our robust portfolio of enabling implants, instruments, and technologies that allow surgeons to simply address complex pathology, as well as our new product pipeline designed to easily solve clinical challenges of spine through innovation.”